Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antisense-oligonucleotides as inhibitors of TGF-R signaling

Antisense-oligonucleotides as inhibitors of TGF-R signaling

US Patent 11213541 · Granted Jan 4, 2022

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Modified short interfering nucleic acid (siNA) molecules and uses thereof2025
Modified short interfering nucleic acid (siNA) molecules and uses thereof2024
Compositions and methods of treating amyotrophic lateral sclerosis (ALS)2024
HNF4a saRNA compositions and methods of use2024
HNF4a saRNA compositions and methods of use2024
Compositions and methods for treating Huntington's disease2024
Compositions and methods for inhibiting expression of RRM2 genes2024
Compositions and methods of treating Huntington's disease2023
Modified short interfering nucleic acid (siNA) molecules and uses thereof2023
Compositions and methods of treating amyotrophic lateral sclerosis (ALS)2023
HNF4A saRNA compositions and methods of use2021
HNF4A saRNA compositions and methods of use2021